Fortress Biotech, Inc. FBIO
$2.79
+2.57%
at last close
Market Cap$92.68 million
P/E Ratio0.88
Div Yield—
Volume702.3K
52-Week Range
$1.76$4.53
Key Stats
- Today's Range
- $2.75 – $2.88
- 50-Day Range
- $2.53 – $3.84
- 52-Week Range
- $1.76 – $4.53
- Volume
- 702K shs
- Average Volume
- 661K shs
- Market Cap
- $92.68 million
- P/E Ratio
- 0.88
- Dividend Yield
- —
Valuation
- P/E Ratio
- 0.88
- Price / Book
- 0.46
- Price / Sales
- 1.40
Short Interest
- Short Interest
- 3.18%
- Days to Cover
- 6.52
Financials (TTM)
- Revenue
- $66.16 million
- Net Income
- $128.94 million
- Net Margin
- 194.89%
- Return on Equity
- 63.71%
- Debt-to-Equity
- 0.19
About Fortress Biotech, Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.
Related Stocks
Compare head-to-head: FBIO vs LLY·FBIO vs JNJ·FBIO vs ABBV·FBIO vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.